These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 34929376)
1. Characterization of the AGR2 Interactome Uncovers New Players of Protein Disulfide Isomerase Network in Cancer Cells. Bouchalova P; Sommerova L; Potesil D; Martisova A; Lapcik P; Koci V; Scherl A; Vonka P; Planas-Iglesias J; Chevet E; Bouchal P; Hrstka R Mol Cell Proteomics; 2022 Feb; 21(2):100188. PubMed ID: 34929376 [TBL] [Abstract][Full Text] [Related]
2. The anterior gradient-2 interactome. Delom F; Mohtar MA; Hupp T; Fessart D Am J Physiol Cell Physiol; 2020 Jan; 318(1):C40-C47. PubMed ID: 31644305 [TBL] [Abstract][Full Text] [Related]
3. Role of pro-oncogenic protein disulfide isomerase (PDI) family member anterior gradient 2 (AGR2) in the control of endoplasmic reticulum homeostasis. Higa A; Mulot A; Delom F; Bouchecareilh M; Nguyên DT; Boismenu D; Wise MJ; Chevet E J Biol Chem; 2011 Dec; 286(52):44855-68. PubMed ID: 22025610 [TBL] [Abstract][Full Text] [Related]
4. Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. Tiemann K; Garri C; Lee SB; Malihi PD; Park M; Alvarez RM; Yap LP; Mallick P; Katz JE; Gross ME; Kani K Oncogene; 2019 Apr; 38(16):3003-3018. PubMed ID: 30575818 [TBL] [Abstract][Full Text] [Related]
5. Effects of ER-resident and secreted AGR2 on cell proliferation, migration, invasion, and survival in PANC-1 pancreatic cancer cells. Hong X; Li ZX; Hou J; Zhang HY; Zhang CY; Zhang J; Sun H; Pang LH; Wang T; Deng ZH BMC Cancer; 2021 Jan; 21(1):33. PubMed ID: 33413231 [TBL] [Abstract][Full Text] [Related]
6. AGR2-mediated unconventional secretion of 14-3-3ε and α-actinin-4, responsive to ER stress and autophagy, drives chemotaxis in canine mammary tumor cells. Yuan SH; Wu CC; Wang YC; Chan XY; Chu HW; Yang Y; Liu HP Cell Mol Biol Lett; 2024 May; 29(1):84. PubMed ID: 38822246 [TBL] [Abstract][Full Text] [Related]
7. The protein disulfide isomerase AGR2 is essential for production of intestinal mucus. Park SW; Zhen G; Verhaeghe C; Nakagami Y; Nguyenvu LT; Barczak AJ; Killeen N; Erle DJ Proc Natl Acad Sci U S A; 2009 Apr; 106(17):6950-5. PubMed ID: 19359471 [TBL] [Abstract][Full Text] [Related]
8. The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarker. Salmans ML; Zhao F; Andersen B Breast Cancer Res; 2013 Apr; 15(2):204. PubMed ID: 23635006 [TBL] [Abstract][Full Text] [Related]
9. Elucidation of the AGR2 Interactome in Esophageal Adenocarcinoma Cells Identifies a Redox-Sensitive Chaperone Hub for the Quality Control of MUC-5AC. Worfolk JC; Bell S; Simpson LD; Carne NA; Francis SL; Engelbertsen V; Brown AP; Walker J; Viswanath YK; Benham AM Antioxid Redox Signal; 2019 Nov; 31(15):1117-1132. PubMed ID: 31436131 [No Abstract] [Full Text] [Related]
10. Control of anterior GRadient 2 (AGR2) dimerization links endoplasmic reticulum proteostasis to inflammation. Maurel M; Obacz J; Avril T; Ding YP; Papadodima O; Treton X; Daniel F; Pilalis E; Hörberg J; Hou W; Beauchamp MC; Tourneur-Marsille J; Cazals-Hatem D; Sommerova L; Samali A; Tavernier J; Hrstka R; Dupont A; Fessart D; Delom F; Fernandez-Zapico ME; Jansen G; Eriksson LA; Thomas DY; Jerome-Majewska L; Hupp T; Chatziioannou A; Chevet E; Ogier-Denis E EMBO Mol Med; 2019 Jun; 11(6):. PubMed ID: 31040128 [TBL] [Abstract][Full Text] [Related]
11. Extracellular AGR2 triggers lung tumour cell proliferation through repression of p21 Fessart D; de Barbeyrac C; Boutin I; Grenier T; Richard E; Begueret H; Bernard D; Chevet E; Robert J; Delom F Biochim Biophys Acta Mol Cell Res; 2021 Mar; 1868(3):118920. PubMed ID: 33278424 [TBL] [Abstract][Full Text] [Related]
12. Anterior gradient protein 2 promotes survival, migration and invasion of papillary thyroid carcinoma cells. Di Maro G; Salerno P; Unger K; Orlandella FM; Monaco M; Chiappetta G; Thomas G; Oczko-Wojciechowska M; Masullo M; Jarzab B; Santoro M; Salvatore G Mol Cancer; 2014 Jun; 13():160. PubMed ID: 24976026 [TBL] [Abstract][Full Text] [Related]
13. Human AGR2 Deficiency Causes Mucus Barrier Dysfunction and Infantile Inflammatory Bowel Disease. Al-Shaibi AA; Abdel-Motal UM; Hubrack SZ; Bullock AN; Al-Marri AA; Agrebi N; Al-Subaiey AA; Ibrahim NA; Charles AK; ; Elawad M; Uhlig HH; Lo B Cell Mol Gastroenterol Hepatol; 2021; 12(5):1809-1830. PubMed ID: 34237462 [TBL] [Abstract][Full Text] [Related]
14. ER stress protein AGR2 precedes and is involved in the regulation of pancreatic cancer initiation. Dumartin L; Alrawashdeh W; Trabulo SM; Radon TP; Steiger K; Feakins RM; di Magliano MP; Heeschen C; Esposito I; Lemoine NR; Crnogorac-Jurcevic T Oncogene; 2017 Jun; 36(22):3094-3103. PubMed ID: 27941872 [TBL] [Abstract][Full Text] [Related]
15. The Sequence-specific Peptide-binding Activity of the Protein Sulfide Isomerase AGR2 Directs Its Stable Binding to the Oncogenic Receptor EpCAM. Mohtar MA; Hernychova L; O'Neill JR; Lawrence ML; Murray E; Vojtesek B; Hupp TR Mol Cell Proteomics; 2018 Apr; 17(4):737-763. PubMed ID: 29339412 [TBL] [Abstract][Full Text] [Related]
16. Dimerization of pro-oncogenic protein Anterior Gradient 2 is required for the interaction with BiP/GRP78. Ryu J; Park SG; Lee PY; Cho S; Lee DH; Kim GH; Kim JH; Park BC Biochem Biophys Res Commun; 2013 Jan; 430(2):610-5. PubMed ID: 23220234 [TBL] [Abstract][Full Text] [Related]
17. Disruption of Paneth and goblet cell homeostasis and increased endoplasmic reticulum stress in Agr2-/- mice. Zhao F; Edwards R; Dizon D; Afrasiabi K; Mastroianni JR; Geyfman M; Ouellette AJ; Andersen B; Lipkin SM Dev Biol; 2010 Feb; 338(2):270-9. PubMed ID: 20025862 [TBL] [Abstract][Full Text] [Related]
18. The estrogen-responsive Agr2 gene regulates mammary epithelial proliferation and facilitates lobuloalveolar development. Verma S; Salmans ML; Geyfman M; Wang H; Yu Z; Lu Z; Zhao F; Lipkin SM; Andersen B Dev Biol; 2012 Sep; 369(2):249-60. PubMed ID: 22819674 [TBL] [Abstract][Full Text] [Related]
19. Anterior gradient proteins in gastrointestinal cancers: from cell biology to pathophysiology. Boisteau E; Posseme C; Di Modugno F; Edeline J; Coulouarn C; Hrstka R; Martisova A; Delom F; Treton X; Eriksson LA; Chevet E; Lièvre A; Ogier-Denis E Oncogene; 2022 Oct; 41(42):4673-4685. PubMed ID: 36068336 [TBL] [Abstract][Full Text] [Related]
20. Emerging roles for the pro-oncogenic anterior gradient-2 in cancer development. Chevet E; Fessart D; Delom F; Mulot A; Vojtesek B; Hrstka R; Murray E; Gray T; Hupp T Oncogene; 2013 May; 32(20):2499-509. PubMed ID: 22945652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]